TERT and cancer: Despite the upregulation of telomere reverse transcriptase (TERT) expression via promoter mutation [127-132] and telomerase activation in most malignant cells, telomeres in cancer are shorter than those in normal tissues: as several studies show, 90% of cancer cells contain short telomeres and high levels of telomerase activity.